title: A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery.
abstract: We compared a fentanyl/isoflurane/propofol regimen with a remifentanil/isoflurane/propofol regimen for fast-track cardiac anesthesia in a prospective, randomized, double-blinded study on patients undergoing elective coronary artery bypass graft surgery. Anesthesia was induced with a 1-min infusion of 0.5 mg/kg propofol followed by 10-mg boluses of propofol every 30 s until loss of consciousness. After 0.2 mg/kg cisatracurium, a blinded continuous infusion of remifentanil at 1 microg. kg(-1). min(-1) or the equivalent volume rate of normal saline was then started. In addition, a blinded bolus syringe of 1 microg/kg remifentanil or 10 microg/kg fentanyl, respectively, was given over 3 min. Blinded remifentanil, 1 microg. kg(-1). min(-1) (or the equivalent volume rate of normal saline), together with 0.5% isoflurane, were used to maintain anesthesia. Significantly more patients (P < 0.01) in the fentanyl regimen experienced hypertension during skin incision and maximum sternal spread compared with patients in the remifentanil regimen. There were no differences between the groups in time until extubation, discharge from the surgical intensive care unit, ST segment and other electrocardiogram changes, catecholamine levels, or cardiac enzymes. The remifentanil-based anesthetic (consisting of a bolus followed by a continuous infusion) resulted in significantly less response to surgical stimulation and less need for anesthetic interventions compared with the fentanyl regimen (consisting of an initial bolus, and followed by subsequent boluses only to treat hemodynamic responses) with both drug regimens allowing early extubation.
  
  
  CONCLUSIONS
  Both fentanyl and the newer opioid remifentanil, when each is combined with isoflurane and propofol, allowed for fast-track cardiac anesthesia. The remifentanil regimen used in this study resulted in significantly less hemodynamic response to surgical stimulation.
authors.affiliation: Department of Anesthesiology, Division of Cardiac Anesthesia, The Ohio State University Medical Center, Doan Hall N408, 410 West 10th Ave., Columbus, OH 43210-1228.
authors.forename: M B
authors.initials: MB
authors.lastname: Howie
authors.forename: D
authors.initials: D
authors.lastname: Cheng
authors.forename: M F
authors.initials: MF
authors.lastname: Newman
authors.forename: E T
authors.initials: ET
authors.lastname: Pierce
authors.forename: C
authors.initials: C
authors.lastname: Hogue
authors.forename: Z
authors.initials: Z
authors.lastname: Hillel
authors.forename: T A
authors.initials: TA
authors.lastname: Bowdle
authors.forename: D
authors.initials: D
authors.lastname: Bukenya
mesh_terms: D000762:Anesthesia Recovery Period; D019162:Anesthetics, Combined; D001794:Blood Pressure; D001026:Coronary Artery Bypass; D003402:Creatine Kinase; D004311:Double-Blind Method; D004562:Electrocardiography; D004837:Epinephrine / Q000097:blood; D005260:Female; D005283:Fentanyl; D006801:Humans; D007442:Intubation, Intratracheal; D007530:Isoflurane; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010880:Piperidines; D015742:Propofol; D011446:Prospective Studies; D000077208:Remifentanil
chemical_list: D019162:Anesthetics, Combined; D010880:Piperidines; D007530:Isoflurane; D003402:Creatine Kinase; D000077208:Remifentanil; D005283:Fentanyl; D009638:Norepinephrine; D015742:Propofol; D004837:Epinephrine